- Coordinator
- Friedrich-Alexander-Universitaet Erlangen-Nuernberg, Germany
- Runs
- 1 January 2027 to 30 June 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101326871
What the project is doing
In the project's own words, from its summary on CORDIS.
We have recently observed an unexpected and profoundly promising synergy: multi-modal out-of-distribution detection methods, originally developed for normative modelling in the ERC MIA-NORMAL project, appear to endow AI agents with remarkable autonomy in real-world scientific reasoning. By explicitly encoding uncertainty and recognising unfamiliar inputs, these agents become capable of detecting anomalies, and they begin to act independently: curating data, identifying patterns, and proposing hypotheses in complex clinical domains.
This breakthrough reframes the role of AI in medicine. No longer confined to fixed-task classification or retrospective association, agentic AI systems can now act as autonomous collaborators in medical discovery. We validated this concept in cardiovascularimaging, where agents independently conducted phenome-wide association studies, rediscovered known correlations, and surfaced novel phenotype-disease links with transparent, explainable logic.
With ORACLE, we aim to extend this paradigm to oncology, focusing on pancreatic cancer, a devastating disease with limited early detection and poor outcomes. Agents will begin with large-scale, multimodal clinical data: radiology, pathology, molecular reports, and labs, and autonomously curate and structure it into patient trajectories. Once organised, agents will explore the data landscape:clustering phenotypes, linking imaging to molecular patterns, and testing hypotheses across cohorts.
When normative data is available, they compare against population-wide baselines; when it is not, agents can use our generative methods to impute missing values and identify structure. Running entirely on real clinical data within GDPR-compliant infrastructure, ORACLE will demonstrate that autonomous AI agents can produce publishable, clinically relevant insights. This PoC may not only advance cancer research but reshape how biomedical discovery is done: transforming it into an automated, data-driven process.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | Erlangen | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI